Publisher
Springer Science and Business Media LLC
Subject
Critical Care and Intensive Care Medicine,Neurology (clinical)
Reference6 articles.
1. Bernhardt K, McClune W, Rowland MJ, Shah A. Hypertonic saline versus other intracranial-pressure-lowering agents for patients with acute traumatic brain injury: a systematic review and meta-analysis. Neurocrit Care. 2023. https://doi.org/10.1007/s12028-023-01771-9.
2. Patil H, Gupta R. A comparative study of bolus dose of hypertonic saline, mannitol, and mannitol plus glycerol combination in patients with severe traumatic brain injury. World Neurosurg. 2019;125:e221–8.
3. Burgess S, Abu-Laban RB, Slavik RS, Vu EN, Zed PJ. A systematic review of randomized controlled trials comparing hypertonic sodium solutions and mannitol for traumatic brain injury: implications for emergency department management. Ann Pharmacother. 2016;50(4):291–300.
4. Lambeck J, Hieber M, Dreßing A, Niesen WD. Central pontine myelinosis and osmotic demyelination syndrome. Dtsch Arztebl Int. 2019;116(35–36):600–6.
5. Khan S, Das S, Batool W, Khan BS, Khan M. Rapid correction of hyponatremia with isotonic saline leading to central pontine myelinolysis. Cureus. 2023;15(4): e38342.